Vietnam welcomes major Indian pharmaceutical investments

Vietnam welcomes major Indian pharmaceutical investments

Leading Indian pharmaceutical corporations have proposed significant investment in Vietnam.
Pharmaceutical players seek expansion of rights in Vietnam

Pharmaceutical players seek expansion of rights in Vietnam

While continuing to make positive business results in Vietnam’s pharma market in the first half of 2024, multinationals are seeking an expansion of their rights.
Promoting Vietnamese pharmaceutical industry

Promoting Vietnamese pharmaceutical industry

The Vietnamese pharmaceutical industry is seeing great advantages.
Imexpharm set growth record in 2023

Imexpharm set growth record in 2023

Imexpharm Corporation announced its business results on March 27, for the fiscal year ending December 31, 2023.
SK Investment Vina III to hold 65 per cent of Imexpharm

SK Investment Vina III to hold 65 per cent of Imexpharm

SK Investment Vina III, a subsidiary of South Korea’s third-largest conglomerate SK Group, is looking to acquire a 65 per cent stake in Imexpharm Pharmaceutical.
Imexpharm raises its status with EU-GMP-standard factories

Imexpharm raises its status with EU-GMP-standard factories

With the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become an industry leader.
DKSH, Hoa Linh, and Thai Minh partner up on development journey

DKSH, Hoa Linh, and Thai Minh partner up on development journey

DKSH, Hoa Linh Pharmaceutical, and Thai Minh Pharmaceutical reveal development and expansion plans that go far into the future.
Vietnamese companies reject illegal wild species-based ingredients and products

Vietnamese companies reject illegal wild species-based ingredients and products

30 companies from Vietnam have committed to stamping out illegal wild species ingredients in their manufacturing and sales of traditional medicines (TM).
MPI calls on investors to make suggestions in pharma sector

MPI calls on investors to make suggestions in pharma sector

The Ministry of Planning and Investment has called on investors and manufacturers to contribute opinions and proposals to attract more investment capital and receive technology transfer to promote the development of the pharmaceutical sector of Vietnam.
More than 200 participants join VIR's conference on pharma and medical sector

More than 200 participants join VIR's conference on pharma and medical sector

Over 200 attendees gathered at the conference to discuss the importance of Resolution No.29-NQ/TW to the sustainable development of Vietnam’s health system.
Retail businesses see potential in pharmaceutical retail

Retail businesses see potential in pharmaceutical retail

In the context of rising inflation, many retail businesses can continue to grow thanks to bolstering their activities in the pharmaceutical sector.
Bayer’s Pharma Business in Asia-Pacific drives growth

Bayer’s Pharma Business in Asia-Pacific drives growth

Bayer announced that 2021 was another record year for its Pharmaceuticals division in the Asia-Pacific region, with robust growth of 4.8 per cent delivering sales of more than $6.3 billion.
Innovating Vietnam's pharmaceutical sector

Innovating Vietnam's pharmaceutical sector

Shareholders and investors highly appreciate Traphaco's progress in innovation and creativity, especially its corporate restructuring strategy.
Pharma rules unable to stand test of time

Pharma rules unable to stand test of time

After four years of enforcement of certain pharmaceutical rules, multinational corporations remain concerned and are changing operations in Vietnam, with import being one of the main focuses.
Mitigating procedural delays in pharmaceutical market

Mitigating procedural delays in pharmaceutical market

While Vietnam has witnessed positive developments in the pharmaceutical and healthcare spheres over the past few years, some issues still need to be ironed out.
|< < 1 2 3 4 > >|